Anti-inflammatory effects of selected drugs on activated neonatal and adult neutrophils

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 5, 2013, Pages 407-413

  Craciun, Eugenia M ^a   Altfelder, Felix ^a   Kuss, Navina ^a   Poeschl, Johannes ^a   Ruef, Peter ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SLK Kliniken Heilbronn GmbH   (Germany)

Author keywords

FK 409; Ketamine; Milrinone; Neutrophil activation; Nitric oxide donors; Piclamilast; Protein C; Urinastatin

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; INTERLEUKIN 8; KETAMINE; LEUKOCYTE ELASTASE; MILRINONE; PICLAMILAST; PROTEIN C; ULINASTATIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL STRUCTURE; ENZYME IMMUNOASSAY; ENZYME RELEASE; HUMAN; LEUKOCYTE ACTIVATION; MALE; MICROSCOPY; NEUTROPHIL; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84882444259     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.796591     Document Type: Article

References (41)

1. Bláha V, Mal'y R, Blazek M, Studnicka J, Andrý sC, Fátorová I, Filip S, Kašparová M, Procházková R, Malý J, Zimov á R, Langrov á H. The importance of rheological parameters in the therapy of microcirculatory disorders. Clin Hemorheol Microcirc 2009; 42 : 37-46.
2. Brus F, Van Oeveren W, Okken A, Oetomo SB. Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity. Pediatrics 1997; 99 : 672-80.
3. Sveger T, Ohlsson K, Mörse H, Polberger S, Laurin S. Plasma neutrophil lipocalin, elastase-1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scand J Clin Lab Invest 2003; 63 : 89-92.
4. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003; 8 : 29-38.
5. Wynn JL, Wong HR. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 2010; 37 : 439-79.
6. Pöschl J MB, Ruef P, Linderkamp O. Deformability of passive and activated neutrophils in children with gramnegative septicaemia. Scand J Clin Lab Invest 2005; 65 : 333-40.
7. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K, Hagberg H. Chemokine and infl ammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999; 45 : 500-9.
8. Downey GP, Elson EL, Schwab BIII, Erzurum C, Young SK, Worthen GS. Biophysical properties and microfi lament assembly in neutrophils: modulation by cyclic AMP. J Cell Biol 1991; 114 : 1179-90.
9. Chang RRK, Chien NTY, Chen CH, Jan KM, Schmid-Schönbein GW, Chien S. Spontaneous activation of circulating granulocytes in patients with acute myocardial and cerebral diseases. Biorheology 1992; 29 : 549-61.
10. J ensen JG, Madsen P, Rix M, Rosthoj S, Ebbesen F. Capillary plasma neutrophil elastase alpha-1-proteinase inhibitor as infection parameter in neonates. Scand J Clin Lab Invest 1996; 56 : 37-40.
11. O'Brien JM, Abraham E. Human models of endotoxemia and recombinant human activated protein C. Crit Care Med 2004; 32 : 202-8.
12. Ruef P, Craciun E, Altfelder E, Simon C, Frommhold D, Koch L, Pö schl J. Effects of phosphodiesterase (III/IV)-inhibitors and cytokines on mechanical properties of neutrophilic granulocytes in neonates and adults. Clin Hemorheol Microcirc 2010; 45 : 301-10.
13. Ruef P, Poeschl J MB, Simon C, Altfelder F, Craciun E, Linderkamp O. Effect of activators and the phosphodiesterase inhibitors pentoxifylline and enoximone on the deformability of neutrophils in neonates and adults. Acta Paediatr 2004; 93 : 1288-93.
14. Giembycz MA. Can the anti-infl ammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking Br J Pharmacol 2008; 155 : 288-90.
15. Kanai T, Ishiwata T, Kobayashi T, Sato H, Takizawa M, Kawamura Y, Tsujimoto H, Nakatani K, Ishibashi N, Nishiyama M, Hatai Y, Asano Y, Kobayashi T, Takeshita S, Nonoyama S. Ulinastatin, aUrinary Trypsin Inhibitor, for the initial treatment of patients with Kawasaki disease. Aretrospective study. Circulation 2011; 124 : 2822-8.
16. McNamara F, Laique PJ, Muang-In S, Whyte HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006; 21 : 217-23.
17. Veldman A, Fischer D, Wong FY, Kreuz W, Sasse M, Eberspächer B, Mansmann U, Schosser R. Human protein Cconcentrate in the treatment of purpura fulminans: aretrospective analysis of safety and outcome in 94 pediatric patients. Critical Care 2010; 14 : 156-63.
18. Yoshida K, Kita Y. Hydroximine NO-donors: FK409 and derivates. Curr Top Med Chem 2005; 5 : 675-85.
19. J oynt C, Bigam DL, Charrois G, Jewell LD, Korbutt G, Cheung PY. Intestinal hemodynamic effects of milrinone in asphyxiated newborn pigs after reoxygenation with 100% oxygen: adose-response study. Shock 2009; 31 : 292-9.
20. Thein M, Roehl AB, Baumert JH, Scherer K, Steendijk P, Rossaint R. Anti-ischemic effectes of inotropic agents in experimental right ventricular infarction. Acta Anaesthesiol Scand 2009; 53 : 941-8.
21. Hatzelmann A, Schudt C. Anti-infl ammatory and immunmodulatory potential of the novel PDE4 inhibitor Rofl umilast in vitro. J Pharmacol Exp Ther 2001; 297 : 267-79.
22. Hiraoka N, Yoshikawa T, Kondo M, Nishioka H, Goto I, Fukuoka J, Ohsawa A, Yokoh S. Reduction in leukocyte elastase levels in patients with sepsis by administration of ulinastatin. Masui 1990; 39 : 367-71.
23. Okumura Y, Inoue H, Fujiyama Y, Bamba T. Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats. J Gastroenterol 1995; 30 : 379-86.
24. Szekely A, Heindl B, Zahler S, Conzen PF, Becker BF. Nonuniform behavior of intravenous anesthetics on postischemic adhesion of neutrophils in the guinea pig heart. Anesth Analg 2000; 90 : 1293-300.
25. Frommhold D, Tschada J, Braach N, Buschmann K, Doerner A, Pflaum J, Stahl MS, Wang H, Koch L, Sperandio M, Bierhaus A, Isermann B, Poeschl J. Protein Cconcentrate controls leukocyte recruitment during infl ammation and improves survival during endotoxinemia after effi cient in vivo activation. Am J Pathol 2011; 179 : 2637-50.
26. Clancy R, Leszczynska J, Amin A, Levartovsky D, Abramson SB. Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J Leukocyte Biol 1995; 58 : 196-202.
27. Ruef P, Craciun E, Frommhold D, Kuss N, Fritzsching B, Pö schl J, Koch L. The NO-donor FK409 improves mechanical properties of activated neonatal PMN. Clin Hemorheol Microcirc 2012; 51 : 293-301.
28. Yasu T, Ikeda N, Ishizuka N, Matsuda E, Kawakami M, Kuroki M, Imai N, Ueba H, Fukuda S, Schmid-Schö nbein GW, Saito M. Nicorandil and leukocyte activation. J Cardiovasc Pharmacol 2002; 40 : 684-92.
29. Lipworth BJ. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet 2005; 365 : 167-75.
30. Kume M, Banafsche R, Yamamoto Y, Yamaoka Y, Nobiling R, Gebhard MM, Klar E. Dynamic changes of postischemic hepatic microcirculation improved by apretreatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res 2006; 136 : 209-18.
31. de Visser YP, Walther FJ, Laghmani EH, Van Wijngaarden S, Nieuwland K, Wagenaar GTM. Phosphodiesterase-4 inhibition attenuates pulmonary infl ammation in neonatal lung injury. Eur Respir J2008; 31 : 633-44.
32. de Visser YP, Walther FJ, Laghmani EH, Steendijk P, Middeldorp M, van der Laarse A, Wagenaar GTM. Phosphodiesterase 4 inhibition attenuates persistenTheart and lung injury by neonatal hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 2012; 302 : 56-67.
33. Sato Y, Walley KR, Klut ME, English D, D'Yachkova Y, Hogg JC, Eeden SF. Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 1999; 159 : 1469-76.
34. Meade VM, Barese CN, Kim C, Nijnibam CG, Marchal CC, Ingram DA, Clapp DW, Dinauer MC, Yoder MC. Rac2 concentrations in umbilical cord neutrophils. Biol Neonate 2006; 90 : 156-9.
35. Baskurt OK, Boynard M, Cokelet GC, Connes P, Cooke BM, Forconi S, Liao F, Hardeman MR, Jung F, Meiselman HJ, Nash G, Nemeth N, Neu B, Sandhagen B, Shin S, Thurston G, Wautier JL. International Expert Panel for Standardization of Hemorheological Methods. New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc 2009; 42 : 75-97.
36. Kalia N, Brown NJ, Hopkinson K, Stephenson TJ, Wood RF, Pockley AG. FK409 inhibits both local and remote organ damage after intestinal ischaemia. J Pathol 2002; 197 : 595-602.
37. Vrints CJ. Pathophysiology of the no-refl ow phenomenon. Acute Card Care 2009; 11 : 69-76.
38. Sutton DW, Schmid-Schönbein GW. Elevation of organ resistance due to leukocyte perfusion. Am J Physiol 1992; 262 : 1646-50.
39. J iang YF, Wang WW, Ye WL, Ni YF, Li J, Chen XL, Jin SW, Lian QQ. Effects of alprostadil and ulinastatin on infl ammatory response and lung injury after cardiopulmonary bypass in pediatric patients with congenital heart diseases. Zhonghua Yi Xue Za Zhi 2008; 88 : 2893-7.
40. Zhou ZQ, Yu YQ, Feng SW, Yu M, Liu HJ, Yang JJ. Ketamine inhibits polymorphonuclear leukocyte CD11b expression and respiratory burst activity in endotoxemic rats. Infl amm Res 2007; 56 : 149-53.
41. Kita Y, Hirasawa Y, Maeda K, Nishio M, Yoshida K. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharmacol 1994; 12 : 123-30.